Mental illness and addiction issue brief: psychotropic medication and children: year end report-2004.
Rosenberg
Matthew
M
D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D003863:Depression / Q000188:drug therapy; D004345:Drug Industry / Q000191:economics; D006300:Health Services Misuse; D006801:Humans; D008605:Mental Health Services / Q000331:legislation & jurisprudence*; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use; D010372:Pediatrics / Q000331:legislation & jurisprudence*; D010818:Practice Patterns, Physicians' / Q000331:legislation & jurisprudence / Q000639:trends; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D013219:State Government; D014481:United States; D014486:United States Food and Drug Administration
D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors